INFUSYSTEM HOLDINGS, INC Cost of Revenue
INFUSYSTEM HOLDINGS, INC (INFU) reported Cost of Revenue of $15.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for the quarter ending 2026-06-30 was $15.52M, a 3.77% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for the quarter ending 2026-03-31 was $14.00M, a 9.95% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for the quarter ending 2025-12-31 was $15.79M, a 1.04% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for the quarter ending 2025-09-30 was $15.67M, a 3.73% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for fiscal 2025 was $63.14M, a 2.04% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for fiscal 2024 was $64.46M, a 2.84% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for fiscal 2023 was $62.68M, a 26.99% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC cost of goods and services sold for fiscal 2022 was $49.35M, a 12.56% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.52M 10-Q · filed 2026-08-04 | $29.52M 10-Q · filed 2026-08-04 | $45.32M derived: sum of 3 quarters · filed 2026-08-04 | $60.98M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $14.00M 10-Q · filed 2026-05-08 | $29.80M derived: sum of 2 quarters · filed 2026-05-08 | $45.47M derived: sum of 3 quarters · filed 2026-05-08 | $61.59M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.46M derived: sum of 2 quarters · filed 2026-02-27 | $47.59M derived: sum of 3 quarters · filed 2026-08-04 | $63.14M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $15.67M 10-Q · filed 2025-11-04 | $31.80M derived: sum of 2 quarters · filed 2026-08-04 | $47.34M 10-Q · filed 2025-11-04 | $62.98M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $16.13M 10-Q · filed 2026-08-04 | $31.68M 10-Q · filed 2026-08-04 | $47.31M derived: sum of 3 quarters · filed 2026-08-04 | $63.58M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $15.55M 10-Q · filed 2026-05-08 | $31.18M derived: sum of 2 quarters · filed 2026-05-08 | $47.46M derived: sum of 3 quarters · filed 2026-05-08 | $64.49M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $15.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.91M derived: sum of 2 quarters · filed 2026-02-27 | $48.94M derived: sum of 3 quarters · filed 2026-02-27 | $64.46M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $16.27M 10-Q · filed 2025-11-04 | $33.30M derived: sum of 2 quarters · filed 2025-11-04 | $48.83M 10-Q · filed 2025-11-04 | $63.89M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $17.03M 10-Q · filed 2025-08-05 | $32.55M 10-Q · filed 2025-08-05 | $47.61M derived: sum of 3 quarters · filed 2025-08-05 | $63.90M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $15.52M 10-Q · filed 2025-05-08 | $30.58M derived: sum of 2 quarters · filed 2025-05-08 | $46.87M derived: sum of 3 quarters · filed 2025-05-08 | $62.78M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $15.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $31.35M derived: sum of 2 quarters · filed 2025-03-11 | $47.26M derived: sum of 3 quarters · filed 2025-03-11 | $62.68M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $16.29M 10-Q · filed 2024-11-08 | $15.66M 10-Q · filed 2023-11-09 | $32.20M derived: sum of 2 quarters · filed 2024-11-08 | $47.62M 10-Q · filed 2024-11-08 | $45.79M 10-Q · filed 2023-11-09 | $62.37M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $15.90M 10-Q · filed 2024-08-09 | $15.29M 10-Q · filed 2023-08-09 | $31.32M 10-Q · filed 2024-08-09 | $30.12M 10-Q · filed 2023-08-09 | $46.08M derived: sum of 3 quarters · filed 2024-08-09 | $57.14M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $15.42M 10-Q · filed 2024-05-09 | $14.83M 10-Q · filed 2023-05-09 | $30.18M derived: sum of 2 quarters · filed 2024-05-09 | $41.24M derived: sum of 3 quarters · filed 2024-05-09 | $53.38M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $25.82M derived: sum of 2 quarters · filed 2024-04-10 | $37.96M derived: sum of 3 quarters · filed 2024-04-10 | $49.35M 10-K · filed 2024-04-10 | $47.34M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $11.06M 10-Q · filed 2023-11-09 | $23.20M derived: sum of 2 quarters · filed 2023-11-09 | $34.60M 10-Q · filed 2023-11-09 | $47.46M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2022-06-30 | $12.14M 10-Q · filed 2023-08-09 | $23.54M 10-Q · filed 2023-08-09 | $36.40M derived: sum of 3 quarters · filed 2024-04-10 | $47.71M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2022-03-31 | $11.40M 10-Q · filed 2023-05-09 | $24.26M derived: sum of 2 quarters · filed 2024-04-10 | $35.57M derived: sum of 3 quarters · filed 2024-04-10 | $45.35M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2021-12-31 | $12.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $24.18M derived: sum of 2 quarters · filed 2024-04-10 | $33.96M derived: sum of 3 quarters · filed 2024-04-10 | $43.85M 10-K · filed 2024-04-10 | $42.19M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $11.31M 10-Q · filed 2022-11-08 | $21.09M derived: sum of 2 quarters · filed 2022-11-08 | $30.98M 10-Q · filed 2022-11-08 | $40.69M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $9.78M 10-Q · filed 2022-08-04 | $19.67M 10-Q · filed 2022-08-04 | $29.39M derived: sum of 3 quarters · filed 2023-03-16 | $39.39M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $9.89M 10-Q · filed 2022-05-05 | $19.60M derived: sum of 2 quarters · filed 2023-03-16 | $29.61M derived: sum of 3 quarters · filed 2023-03-16 | $39.63M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $19.72M derived: sum of 2 quarters · filed 2023-03-16 | $29.74M derived: sum of 3 quarters · filed 2023-03-16 | $38.63M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $10.00M 10-Q · filed 2021-11-15 | $20.02M derived: sum of 2 quarters · filed 2021-11-15 | $28.91M 10-Q · filed 2021-11-15 | $37.68M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-06-30 | $10.02M 10-Q · filed 2021-08-12 | $18.91M 10-Q · filed 2021-08-12 | $27.67M derived: sum of 3 quarters · filed 2022-03-15 | $36.92M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-03-31 | $8.89M 10-Q · filed 2021-05-10 | $17.65M derived: sum of 2 quarters · filed 2022-03-15 | $26.90M derived: sum of 3 quarters · filed 2022-03-15 | $35.27M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2019-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $18.01M derived: sum of 2 quarters · filed 2022-03-15 | $26.38M derived: sum of 3 quarters · filed 2022-03-15 | $34.23M 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | $9.25M 10-Q · filed 2020-11-13 | $17.62M derived: sum of 2 quarters · filed 2020-11-13 | $25.47M 10-Q · filed 2020-11-13 | $33.06M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $8.37M 10-Q · filed 2020-08-14 | $16.22M 10-Q · filed 2020-08-14 | $23.81M derived: sum of 3 quarters · filed 2020-08-14 | $30.81M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $7.85M 10-Q · filed 2020-05-15 | $15.44M derived: sum of 2 quarters · filed 2020-05-15 | $22.45M derived: sum of 3 quarters · filed 2020-05-15 | $29.17M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $14.59M derived: sum of 2 quarters · filed 2020-03-30 | $21.32M derived: sum of 3 quarters · filed 2020-03-30 | $27.57M 10-K · filed 2020-03-30 | $19.33M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $7.00M 10-Q · filed 2019-11-14 | $4.90M 10-Q · filed 2018-11-13 | $13.73M derived: sum of 2 quarters · filed 2019-11-14 | $19.98M 10-Q · filed 2019-11-14 | $14.18M 10-Q · filed 2018-11-13 | $24.73M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $6.73M 10-Q · filed 2019-08-14 | $4.80M 10-Q · filed 2018-08-14 | $12.97M 10-Q · filed 2019-08-14 | $9.28M 10-Q · filed 2018-08-14 | $17.73M derived: sum of 3 quarters · filed 2019-08-14 | $22.18M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $6.25M 10-Q · filed 2019-05-15 | $4.48M 10-Q · filed 2018-05-14 | $11.00M derived: sum of 2 quarters · filed 2019-05-15 | $15.45M derived: sum of 3 quarters · filed 2019-05-15 | $20.08M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $9.21M derived: sum of 2 quarters · filed 2019-03-22 | $13.83M derived: sum of 3 quarters · filed 2019-03-22 | $18.37M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $4.45M 10-Q · filed 2018-11-13 | $9.08M derived: sum of 2 quarters · filed 2018-08-14 | $13.61M 10-Q · filed 2018-11-13 | $17.50M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-06-30 | $4.62M 10-Q · filed 2018-08-14 | $9.16M 10-Q · filed 2018-08-14 | $13.05M derived: sum of 3 quarters · filed 2018-08-14 | $17.07M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $4.54M 10-Q · filed 2018-05-14 | $8.43M derived: sum of 2 quarters · filed 2018-05-14 | $12.45M derived: sum of 3 quarters · filed 2018-05-14 | $17.24M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $7.91M derived: sum of 2 quarters · filed 2018-03-19 | $12.70M derived: sum of 3 quarters · filed 2018-03-19 | $16.21M 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $4.02M 10-Q · filed 2017-11-13 | $8.81M derived: sum of 2 quarters · filed 2017-11-13 | $12.31M 10-Q · filed 2017-11-13 | $15.86M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $4.79M 10-Q · filed 2017-08-09 | $8.29M 10-Q · filed 2017-08-09 | $11.85M derived: sum of 3 quarters · filed 2017-08-09 | $15.43M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $3.51M 10-Q · filed 2017-05-15 | $7.06M derived: sum of 2 quarters · filed 2017-05-15 | $10.64M derived: sum of 3 quarters · filed 2017-05-15 | $14.29M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $7.13M derived: sum of 2 quarters · filed 2017-03-22 | $10.79M derived: sum of 3 quarters · filed 2017-03-22 | $13.80M 10-K · filed 2017-03-22 | ||||
| 2015-09-30 | $3.58M 10-Q · filed 2016-12-12 | $7.24M derived: sum of 2 quarters · filed 2016-12-12 | $10.25M 10-Q · filed 2016-12-12 | $13.39M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2015-06-30 | $3.66M 10-Q/A · filed 2016-12-12 | $6.67M 10-Q/A · filed 2016-12-12 | $9.81M derived: sum of 3 quarters · filed 2016-12-12 | $13.03M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2015-03-31 | $3.02M 10-Q/A · filed 2016-12-12 | $6.16M derived: sum of 2 quarters · filed 2016-12-12 | $9.38M derived: sum of 3 quarters · filed 2016-12-12 | $12.29M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-12-31 | $3.14M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $6.36M derived: sum of 2 quarters · filed 2016-12-12 | $9.28M derived: sum of 3 quarters · filed 2016-12-12 | $12.16M 10-K/A · filed 2016-12-12 | ||||
| 2014-09-30 | $3.22M 10-Q · filed 2015-11-12 | $6.13M derived: sum of 2 quarters · filed 2015-11-12 | $9.02M 10-Q · filed 2015-11-12 | $12.12M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $2.91M 10-Q · filed 2015-08-13 | $5.80M 10-Q · filed 2015-08-13 | $8.90M derived: sum of 3 quarters · filed 2015-08-13 | $11.65M derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $2.89M 10-Q · filed 2015-05-12 | $5.99M derived: sum of 2 quarters · filed 2015-05-12 | $8.74M derived: sum of 3 quarters · filed 2015-05-12 | $11.59M derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2013-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $5.85M derived: sum of 2 quarters · filed 2015-03-09 | $8.70M derived: sum of 3 quarters · filed 2015-03-09 | $11.27M 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $2.75M 10-Q · filed 2014-11-10 | $5.59M derived: sum of 2 quarters · filed 2014-11-10 | $8.17M 10-Q · filed 2014-11-10 | $10.58M derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | $2.85M 10-Q · filed 2014-08-01 | $5.42M 10-Q · filed 2014-08-01 | $7.83M derived: sum of 3 quarters · filed 2014-08-01 | $10.21M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2013-03-31 | $2.58M 10-Q · filed 2014-05-05 | $4.98M derived: sum of 2 quarters · filed 2014-05-05 | $7.36M derived: sum of 3 quarters · filed 2014-05-05 | $9.51M derived: sum of 4 quarters · filed 2014-05-05 | ||||
| 2012-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $4.78M derived: sum of 2 quarters · filed 2014-03-11 | $6.93M derived: sum of 3 quarters · filed 2014-03-11 | $9.16M 10-K · filed 2014-03-11 | ||||
| 2012-09-30 | $2.38M 10-Q · filed 2013-11-12 | $4.53M derived: sum of 2 quarters · filed 2013-11-12 | $6.76M 10-Q · filed 2013-11-12 | $9.23M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $2.15M 10-Q · filed 2013-08-13 | $4.38M 10-Q · filed 2013-08-13 | $6.85M derived: sum of 3 quarters · filed 2013-08-13 | $9.20M derived: sum of 4 quarters · filed 2013-08-13 | ||||
| 2012-03-31 | $2.23M 10-Q · filed 2013-05-13 | $4.70M derived: sum of 2 quarters · filed 2013-05-13 | $7.05M derived: sum of 3 quarters · filed 2013-05-13 | $9.22M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $4.81M derived: sum of 2 quarters · filed 2013-03-28 | $6.99M derived: sum of 3 quarters · filed 2013-03-28 | $9.13M 10-K · filed 2013-03-28 | ||||
| 2011-09-30 | $2.35M 10-Q · filed 2012-11-14 | $4.52M derived: sum of 2 quarters · filed 2012-11-14 | $6.66M 10-Q · filed 2012-11-14 | $8.87M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $2.17M 10-Q · filed 2012-08-08 | $4.32M 10-Q · filed 2012-08-08 | $6.52M derived: sum of 3 quarters · filed 2012-08-08 | $8.65M derived: sum of 4 quarters · filed 2012-08-08 | ||||
| 2011-03-31 | $2.14M 10-Q · filed 2012-05-21 | $4.35M derived: sum of 2 quarters · filed 2012-05-21 | $6.48M derived: sum of 3 quarters · filed 2012-05-21 | $8.20M derived: sum of 4 quarters · filed 2012-05-21 | ||||
| 2010-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $4.34M derived: sum of 2 quarters · filed 2012-03-16 | $6.05M derived: sum of 3 quarters · filed 2012-03-16 | $7.73M 10-K · filed 2012-03-16 | ||||
| 2010-09-30 | $2.13M 10-Q · filed 2011-11-14 | $3.85M derived: sum of 2 quarters · filed 2011-11-14 | $5.52M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $1.72M 10-Q · filed 2011-08-15 | $3.39M 10-Q · filed 2011-08-15 | ||||||
| 2009-12-31 | $6.20M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |